(Q48869697)

16 February 2018

title

Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases. (English)

1 reference

16 February 2018

author

Héctor R. Martínez

2

1 reference

16 February 2018

author name string

Rangel-Guerra RA

1

1 reference

16 February 2018

Sáenz C

3

1 reference

16 February 2018

Bosques-Padilla F

4

1 reference

16 February 2018

Estrada-Bellmann I

5

1 reference

16 February 2018

publication date

1 November 1996

1 reference

16 February 2018

Journal of the Neurological Sciences

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 February 2018

volume

143

1 reference

16 February 2018

issue

1-2

1 reference

16 February 2018

page(s)

19-30

1 reference

16 February 2018

Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Treatment of fungal infections of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Pulmonary and rhinocerebral mucormycosis. Successful outcome with amphotericin B and griseofulvin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

The air crescent sign of invasive pulmonary mucormycosis in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Cutaneous phycomycosis. Report of three cases with identification of Rhizopus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Mucormycosis in a Transplant Recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Rhinocerebral Phycomycosis and Internal Carotid Artery Thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Phycomycosis complicating leukemia and lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Rhinocerebral mucormycosis: premortem diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Strategies in the treatment of systemic fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

The clinical presentation and diagnosis of invasive fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Mucormycosis. Report of 11 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Successfully Treated Rhinocerebral Phycomycosis in Well Controlled Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Rhinocerebral mucormycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Survival factors in rhino-orbital-cerebral mucormycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

Mucormycosis in trauma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900148-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(96)00148-7

1 reference

16 February 2018

1 reference

16 February 2018